A TRIM5α-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry

Virology

Volumn 363, Issue 2, 2007, Pages 310-318

  Pineda, Mario Javier ^a,b   Orton, Brannon R ^a   Overbaugh, Julie ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CCR5; Coreceptor; Entry; HIV; Macaque cells; Post entry; TRIM5

Indexed keywords

CHEMOKINE RECEPTOR CCR5; TRIPARTITE MOTIF PROTEIN 5; CARRIER PROTEIN; CD4 ANTIGEN; TRIM5 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOFLUORESCENCE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS REPLICATION; ANIMAL; CELL LINE; EPITHELIUM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGENS, CD4; CARRIER PROTEINS; CELL LINE; EPITHELIAL CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; RECEPTORS, CCR5; VIRUS REPLICATION;

EID: 34248517042     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.02.002     Document Type: Article

References (24)

1. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17 (1999) 657-700
2. Bieniasz P.D. Restriction factors: a defense against retroviral infection. Trends Microbiol. 11 6 (2003) 286-291
3. Bukrinskaya A., Brichacek B., Mann A., and Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188 11 (1998) 2113-2125
4. Chackerian B., Haigwood N.L., and Overbaugh J. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 213 (1995) 386-394
5. Chackerian B., Long E.M., Luciw P.A., and Overbaugh J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71 5 (1997) 3932-3939
6. Cheng-Mayer C., Quiroga M., Tung J.W., Dina D., and Levy J.A. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64 9 (1990) 4390-4398
7. Cowan S., Hatziioannou T., Cunningham T., Muesing M.A., Gottlinger H.G., and Bieniasz P.D. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. U. S. A. 99 18 (2002) 11914-11919
8. Long E.M., Rainwater S.M.J., Lavreys L., Mandaliya K., and Overbaugh J. HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. AIDS Res. Hum. Retroviruses 18 8 (2002) 567-576
9. Marchant D., Neil S.J., Aubin K., Schmitz C., and McKnight A. An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type 1 (HIV-1) and HIV-2 to Lv2 restriction. J. Virol. 79 15 (2005) 9410-9418
10. McKnight A., Griffiths D.J., Dittmar M., Clapham P., and Thomas E. Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2. J. Virol. 75 15 (2001) 6914-6922
11. Munk C., Brandt S.M., Lucero G., and Landau N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. U. S. A. 99 21 (2002) 13843-13848
12. Naldini L., Blomer U., Gage F.H., Trono D., and Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 93 21 (1996) 11382-11388
13. Pohlmann S., Davis C., Meister S., Leslie G.J., Otto C., Reeves J.D., Puffer B.A., Papkalla A., Krumbiegel M., Marzi A., Lorenz S., Munch J., Doms R.W., and Kirchhoff F. Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors. J. Virol. 78 7 (2004) 3223-3232
14. Popik W., Alce T.M., and Au W.C. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J. Virol. 76 10 (2002) 4709-4722
15. Rousseau C.M., Nduati R.W., Richardson B.A., John-Stewart G.C., Mbori-Ngacha D.A., Kreiss J.K., and Overbaugh J. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J. Infect. Dis. 190 10 (2004) 1880-1888
16. Schmidtmayerova H., Alfano M., Nuovo G., and Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72 6 (1998) 4633-4642
17. Schmitz C., Marchant D., Neil S.J., Aubin K., Reuter S., Dittmar M.T., and McKnight A. Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J. Virol. 78 4 (2004) 2006-2016
18. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 6977 (2004) 848-853
19. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., and Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U. S. A. 103 14 (2006) 5514-5519
20. Yamashita M., and Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 78 11 (2004) 5670-5678
21. York-Higgins D., Cheng-Mayer C., Bauer D., Levy J.A., and Dina D. Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J. Virol. 64 8 (1990) 4016-4020
22. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., and Chen I.S.Y. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 (1990) 213-222
23. Zheng Y.-H., and Peterlin B.M. Intracellular immunity to HIV-1: newly defined battles inside infected cells. Retrovirology 2 25 (2005) 1-13
24. Zufferey R., Nagy D., Mandel R.J., Naldini L., and Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15 9 (1997) 871-875